Antihypertrophic effect of Na+/H+ exchanger isoform 1 inhibition is mediated by reduced mitogen-activated protein kinase activation secondary to improved mitochondrial integrity and decreased generation of mitochondrial-derived reactive oxygen species

The Journal of Pharmacology and Experimental Therapeutics
Sabzali JavadovMorris Karmazyn

Abstract

Although inhibition of Na+/H+ exchanger isoform 1 (NHE-1) reduces cardiomyocyte hypertrophy, the mechanisms underlying this effect are not known. Recent evidence suggests that this may be associated with improved mitochondrial function. To understand the mechanistic bases for mitochondrial involvement in the antihypertrophic effect of NHE-1 inhibition, we examined the effect of the NHE-1-specific inhibitor N-[2-methyl-4,5-bis(methylsulphonyl)-benzoyl]-guanidine, hydrochloride (EMD, EMD87580; 5 microM) on the hypertrophic phenotype, mitogen-activated protein kinase (MAPK) activity, mitochondrial membrane potential (Deltapsim), permeability transition (MPT) pore opening, and superoxide generation in phenylephrine (PE)-treated neonatal rat cardiomyocytes. EMD significantly suppressed markers of cell hypertrophy, including cell surface area and gene expression of atrial natriuretic peptide and alpha-skeletal actin. EMD inhibited the PE-induced MPT pore opening, prevented the loss in Deltapsim, and attenuated superoxide generation induced by PE. Moreover, the activation of p38 MAPK (p38) and extracellular signal-regulated kinase (ERK) 1/2 MAPKs induced by PE was significantly attenuated in the presence of EMD as well as the antioxid...Continue Reading

References

Mar 1, 1985·Archives of Biochemistry and Biophysics·J F TurrensA L Lehninger
Feb 3, 2000·Proceedings of the National Academy of Sciences of the United States of America·T TaigenJ D Molkentin
Jul 13, 2000·Cell·E N Olson, R S Williams
Jan 3, 2001·Journal of Molecular and Cellular Cardiology·J K AminW S Colucci
Feb 24, 2001·Journal of the American College of Cardiology·K TanakaT Takabatake
Apr 18, 2001·Circulation·R M GurevichL A Kirshenbaum
Mar 1, 2002·Journal of the American College of Cardiology·Metin Avkiran, Michael S Marber
Sep 5, 2002·Free Radical Biology & Medicine·Paul S BrookesVictor M Darley-Usmar
Oct 25, 2002·American Journal of Physiology. Cell Physiology·M R SayenRoberta A Gottlieb
Feb 8, 2003·Hypertension·Horacio E CingolaniMaría C Camilión de Hurtado
Aug 2, 2003·Circulation Research·Venkatesh RajapurohitamMorris Karmazyn
Sep 25, 2003·Naunyn-Schmiedeberg's Archives of Pharmacology·Wolfgang J Linz, Andreas E Busch
Nov 6, 2003·The Journal of Biological Chemistry·Yurii V MukhinJohn R Raymond
Sep 10, 2004·American Journal of Physiology. Cell Physiology·Paul S BrookesShey-Shing Sheu

❮ Previous
Next ❯

Citations

Jan 4, 2012·Basic Research in Cardiology·Jakob VoelklFlorian Lang
Oct 12, 2012·Journal of Physiology and Biochemistry·Bryan J Feger, Joseph W Starnes
Aug 19, 2009·Cardiovascular Research·Xiaohong Tracey GanMorris Karmazyn
May 19, 2009·Applied Physiology, Nutrition, and Metabolism = Physiologie Appliquée, Nutrition Et Métabolisme·Renée Ventura-Clapier
Jun 28, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Sabzali Javadov, Morris Karmazyn
Nov 6, 2007·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Stine Falsig PedersenElse Kay Hoffmann
Apr 8, 2011·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Sabzali JavadovRebecca Parodi-Rullan
Mar 4, 2008·American Journal of Respiratory and Critical Care Medicine·Lunyin YuCharles A Hales
Apr 21, 2012·EMBO Molecular Medicine·Rongxue WuHossein Ardehali
May 27, 2014·European Journal of Pharmacology·Juliana FantinelliSusana M Mosca
Mar 26, 2009·Journal of Molecular and Cellular Cardiology·Sabzali JavadovMorris Karmazyn
Mar 11, 2008·Journal of Molecular and Cellular Cardiology·Morris KarmazynSabzali Javadov
Jan 15, 2008·Journal of Molecular and Cellular Cardiology·Larry Fliegel
May 8, 2007·European Journal of Pharmacology·Juno KimKyung Hwan Kim
Dec 15, 2010·Journal of Cellular and Molecular Medicine·Shiang Y LimDerek M Yellon
Oct 1, 2015·International Journal of Cell Biology·Prabhakar Singh, Syed Ibrahim Rizvi
Oct 2, 2013·Journal of Molecular and Cellular Cardiology·Vikram PrasadGary E Shull
Oct 10, 2012·International Journal of Cardiology·Lu-Yu ZhouPei-Feng Li
Mar 11, 2017·Biochimica Et Biophysica Acta. Bioenergetics·Andrey V KuznetsovMichael Grimm
Mar 7, 2007·Circulation·Horacio E Cingolani, Irene L Ennis
Apr 3, 2019·International Journal of Molecular Sciences·Bowen HuHongmei Li
Sep 20, 2008·Journal of Applied Physiology·Carolina D GarciarenaIrene L Ennis
Jul 17, 2008·Molecular Pharmacology·Mary L García-CazarínMichael T Piascik
Jun 11, 2009·The Journal of Pharmacology and Experimental Therapeutics·Sabzali JavadovNelson Escobales
Apr 6, 2021·Frontiers in Cell and Developmental Biology·Bowen HuXiquan Zhang
Feb 27, 2007·Archives of Biochemistry and Biophysics·Stine Falsig PedersenMaria Rasmussen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.